Tech Transfer eNews Blog
Industry-Sponsored Research Management sample issue

New forecasting and valuation tool designed specifically for new drug candidates


By Jesse Schwartz
Published: April 4th, 2018

Easy eNPV is a tool that provides its users with unprecedented ability to efficiently and accurately forecast the financial performance of new drug candidates and produce valuations. It is not a costly subscription product — some of which run in the tens of thousands for a year. Rather, it’s available for one-time purchase — and with unlimited use — at a very modest price.

Valuation and forecasting for new drug candidates is critical in directing product strategy, attracting licensees, and communicating potential value to investors — but generic financial models are simply not equipped to handle the unique complexities associated with pharmaceuticals and biotechnology. Now, with the Easy eNPV valuation and forecasting tool, users have a fully automated and user-friendly model that efficiently facilitates this vital strategic task in drug development and licensing.

For complete details and to order, CLICK HERE >>

Posted under: Tech Transfer e-News

Twitter Facebook Linkedin Pinterest Email

No Comments so far ↓

There are no comments yet...Kick things off by filling out the form below.

Leave a Comment